Quadrivalent HPV Vaccine | CERVAVAC - Serum Institute

Advanced Cervical Cancer & HPV Prevention

When protecting patients—particularly adolescents and young adults—against the severe health risks associated with the Human Papillomavirus (HPV), healthcare providers require a highly reliable and targeted clinical intervention. The Quadrivalent Human Papilloma Virus (Serotypes 6, 11, 16 & 18) Vaccine (Recombinant) (commercially recognized as CERVAVAC) provides powerful, active immunization. Manufactured by the Serum Institute of India (SII), a global powerhouse in specialized immunology, this single-dose vial ensures the steady clinical performance necessary for critical preventative healthcare protocols.

Why Choose CERVAVAC for Clinical Immunization?

Shielding patients from the most dangerous strains of HPV—those responsible for the majority of cervical, vulvar, and vaginal cancers, as well as genital warts—requires a sophisticated recombinant formulation. Instead of relying on live viruses, clinical specialists benefit from CERVAVAC's utilization of Virus-Like Particles (VLPs). This advanced technology safely and effectively prompts a robust immune response, establishing long-lasting T-cell memory. Meeting rigorous safety standards, CERVAVAC provides clinics, hospitals, and pediatric/gynecological practices with a gold-standard defense against HPV.

Key Product Specifications & Clinical Benefits

Quadrivalent Broad Coverage: Delivers targeted active protection against the four highest-risk serotypes of Human Papillomavirus: 6, 11, 16, and 18.

Advanced Recombinant Technology: Formulated as a sterile suspension of recombinant VLPs, ensuring high immunogenicity without the risks associated with live vaccines.

Precise Single-Dose Vial: Supplied as a ready-to-use 0.5 ml single-dose vial, ensuring exact clinical dosing and minimizing preparation time.

Targeted Administration: Formulated strictly for injection, guaranteeing optimal absorption and systemic immune activation.

Essential Storage & Usage Guidelines

Maintaining the delicate biological integrity of this recombinant vaccine is absolutely vital for its clinical efficacy.

• Strict Cold Chain: Store the vial strictly in a refrigerator between 2°C to 8°C (36°F to 46°F).

• Do Not Freeze: Freezing will irrevocably destroy the active vaccine structure. Discard immediately if the vaccine has been frozen. Protect strictly from light. Refer to the enclosed prescribing information for exact age-based dosing schedules (typically a 2-dose or 3-dose series depending on the patient's age at initiation) as directed by the physician.

Important Notice: CERVAVAC is a Prescription Drug. It must be prescribed, handled, and administered strictly by a Registered Medical Practitioner in a clinical or hospital setting. Keep all medicines safely out of the reach of children.